Use of quinolinone derivative in treatment of immune thrombocytopenia
AssigneeChia Tai Tianqing Pharmaceutical Group Co., Ltd.
InventorsQian ZHAO, Xunqiang WANG, Xiquan ZHANG, Ding YU
Life of this patent
Estimating the term…
Abstract
The present invention relates to a use of a quinolinone derivative in treatment of immune thrombocytopenia, and in particular to a use of a compound of formula (I) or a pharmaceutically-acceptable salt or pharmaceutical composition thereof in treatment of immune thrombocytopenia.
Claims21
1-15. (canceled)
A method of treating or preventing immune thrombocytopenia in a subject, comprising administering to a subject in need thereof a therapeutically effective amount or a prophylactically effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition thereof:
Dependencies are inferred from the claim text.